Header Logo

Michael Cookson

Concepts (581)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
90
2024
162
12.890
Why?
Prostatic Neoplasms
84
2024
277
12.490
Why?
Cystectomy
76
2024
103
9.900
Why?
Prostatectomy
51
2020
83
6.980
Why?
Carcinoma, Transitional Cell
33
2023
55
4.230
Why?
Urology
12
2021
29
3.650
Why?
Prostatic Neoplasms, Castration-Resistant
8
2020
13
3.600
Why?
Male
196
2024
13424
2.910
Why?
Prostate-Specific Antigen
23
2024
53
2.650
Why?
Kidney Neoplasms
22
2020
101
2.640
Why?
Robotics
11
2020
43
2.460
Why?
Humans
238
2024
27968
2.460
Why?
Aged
132
2024
5383
2.390
Why?
Urinary Diversion
20
2018
26
2.330
Why?
Neoplasm Staging
48
2023
478
2.270
Why?
Neoplasm Recurrence, Local
28
2021
330
2.260
Why?
Androgen Antagonists
12
2020
17
2.160
Why?
Middle Aged
135
2024
7111
2.120
Why?
Prostate
16
2020
52
2.020
Why?
Nephrectomy
16
2017
48
1.910
Why?
Laparoscopy
13
2014
146
1.900
Why?
Postoperative Complications
25
2019
611
1.810
Why?
Blood Loss, Surgical
15
2013
53
1.620
Why?
Treatment Outcome
55
2024
2367
1.610
Why?
Neoadjuvant Therapy
14
2023
73
1.590
Why?
Neoplasm Invasiveness
35
2024
188
1.530
Why?
Medical Oncology
4
2021
93
1.510
Why?
Lymph Node Excision
15
2014
100
1.510
Why?
Carcinoma, Renal Cell
14
2017
77
1.500
Why?
Aged, 80 and over
57
2024
2015
1.480
Why?
Antineoplastic Agents
9
2021
679
1.410
Why?
Prognosis
28
2020
802
1.360
Why?
Antineoplastic Combined Chemotherapy Protocols
8
2022
407
1.350
Why?
Retrospective Studies
53
2023
2541
1.190
Why?
Quality of Life
9
2024
484
1.080
Why?
Patient Preference
2
2018
32
1.080
Why?
Practice Guidelines as Topic
7
2020
242
1.060
Why?
Urinary Reservoirs, Continent
9
2018
13
1.030
Why?
Female
87
2024
15074
0.960
Why?
Carcinoma
5
2014
74
0.920
Why?
Adult
65
2021
7703
0.910
Why?
Robotic Surgical Procedures
5
2019
45
0.900
Why?
Ablation Techniques
3
2020
12
0.900
Why?
Carcinoma in Situ
10
2024
45
0.880
Why?
Antineoplastic Agents, Hormonal
6
2020
29
0.850
Why?
Length of Stay
16
2014
228
0.830
Why?
Urologic Neoplasms
4
2017
13
0.820
Why?
Germ-Line Mutation
2
2020
30
0.820
Why?
Chemotherapy, Adjuvant
12
2020
113
0.810
Why?
Blood Transfusion
7
2013
77
0.810
Why?
Lymph Nodes
3
2012
103
0.800
Why?
Genetic Testing
2
2020
68
0.790
Why?
Salvage Therapy
5
2020
34
0.770
Why?
Societies, Medical
7
2021
92
0.750
Why?
Disease Management
3
2018
88
0.740
Why?
United States
22
2020
2139
0.730
Why?
Biopsy, Needle
11
2013
48
0.730
Why?
Survival Rate
22
2021
428
0.710
Why?
Urologic Surgical Procedures
3
2017
23
0.710
Why?
Androstenes
2
2020
3
0.700
Why?
Osteoporotic Fractures
1
2020
5
0.700
Why?
Evidence-Based Medicine
6
2021
144
0.700
Why?
Follow-Up Studies
29
2024
1011
0.690
Why?
Urinary Bladder Diseases
3
2013
9
0.680
Why?
Osteoporosis
1
2020
63
0.670
Why?
BCG Vaccine
6
2024
13
0.660
Why?
Prospective Studies
29
2021
1244
0.650
Why?
Immunotherapy
4
2024
159
0.640
Why?
Nutritional Status
2
2018
77
0.640
Why?
Cohort Studies
18
2021
884
0.590
Why?
Urologic Diseases
1
2018
6
0.580
Why?
Perioperative Care
2
2019
35
0.580
Why?
Algorithms
3
2018
430
0.580
Why?
Clinical Decision-Making
1
2018
63
0.580
Why?
Neoplasm Grading
7
2020
104
0.570
Why?
Hospitals
3
2020
76
0.550
Why?
Disease Progression
10
2020
472
0.530
Why?
Clostridium Infections
1
2017
67
0.530
Why?
Drug Resistance, Neoplasm
4
2020
166
0.510
Why?
Testicular Neoplasms
3
2006
16
0.510
Why?
Survival Analysis
8
2016
287
0.510
Why?
Ultrasound, High-Intensity Focused, Transrectal
1
2015
4
0.490
Why?
Risk Factors
27
2020
2078
0.470
Why?
Time Factors
18
2020
1590
0.470
Why?
Body Mass Index
7
2011
397
0.470
Why?
Critical Pathways
4
2005
16
0.470
Why?
Patient Readmission
4
2014
103
0.460
Why?
Radiotherapy, Adjuvant
3
2020
60
0.450
Why?
Practice Patterns, Physicians'
3
2013
163
0.450
Why?
Consensus
5
2022
74
0.450
Why?
Neoplasms, Germ Cell and Embryonal
2
2005
16
0.440
Why?
Tumor Burden
4
2013
110
0.440
Why?
Vena Cava, Inferior
2
2011
16
0.440
Why?
Risk Assessment
10
2018
610
0.420
Why?
Osteoradionecrosis
1
2013
1
0.420
Why?
Pubic Bone
1
2013
3
0.410
Why?
Combined Modality Therapy
8
2021
297
0.410
Why?
Biomarkers, Tumor
8
2018
404
0.410
Why?
Disease-Free Survival
11
2018
237
0.410
Why?
Radiation Injuries
1
2013
52
0.400
Why?
Administration, Intravesical
8
2024
16
0.400
Why?
Fractures, Bone
1
2013
45
0.400
Why?
Multivariate Analysis
10
2017
302
0.400
Why?
Biopsy
4
2010
206
0.380
Why?
Early Detection of Cancer
5
2024
126
0.380
Why?
Vena Cava Filters
1
2011
11
0.380
Why?
Internship and Residency
3
2017
239
0.380
Why?
Equipment Failure
1
2011
31
0.370
Why?
Erythrocyte Transfusion
1
2011
15
0.370
Why?
Dietary Supplements
3
2019
240
0.370
Why?
Genetic Predisposition to Disease
3
2020
665
0.360
Why?
Neoplasms, Multiple Primary
2
2018
26
0.350
Why?
Neoplasms, Second Primary
3
2009
21
0.340
Why?
Urothelium
4
2015
35
0.330
Why?
Renal Insufficiency
1
2009
20
0.330
Why?
Kidney
3
2017
283
0.330
Why?
Proportional Hazards Models
10
2020
225
0.320
Why?
Adenocarcinoma
3
2020
297
0.320
Why?
Physicians
2
2012
83
0.320
Why?
Cystoscopy
4
2018
16
0.320
Why?
Prostatic Intraepithelial Neoplasia
4
2011
10
0.310
Why?
Sarcopenia
2
2019
42
0.310
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2008
11
0.300
Why?
Health Planning Councils
1
2008
2
0.300
Why?
Patient Selection
7
2016
148
0.300
Why?
Cystitis
2
2013
11
0.300
Why?
Erectile Dysfunction
4
2007
15
0.290
Why?
Gonadotropin-Releasing Hormone
3
2020
37
0.290
Why?
Surveys and Questionnaires
7
2014
967
0.290
Why?
Bone Marrow Neoplasms
1
2007
2
0.280
Why?
Age Factors
10
2021
733
0.280
Why?
Incidence
11
2018
562
0.270
Why?
Research Report
2
2017
23
0.270
Why?
Bone Marrow
1
2007
76
0.270
Why?
Checklist
2
2017
22
0.270
Why?
Adjuvants, Immunologic
4
2024
67
0.260
Why?
Predictive Value of Tests
8
2014
474
0.260
Why?
Urinary Incontinence
3
2013
20
0.260
Why?
Natural Orifice Endoscopic Surgery
2
2016
8
0.260
Why?
Testosterone
2
2020
72
0.260
Why?
Thrombocytopenia
1
2007
113
0.250
Why?
Insurance, Health
2
2017
51
0.250
Why?
Quality Improvement
2
2017
115
0.250
Why?
Urethra
4
2016
33
0.250
Why?
Prostatic Hyperplasia
4
2010
8
0.240
Why?
Lymphatic Metastasis
5
2012
125
0.240
Why?
Ureteral Obstruction
2
2009
12
0.240
Why?
Kaplan-Meier Estimate
7
2015
194
0.230
Why?
Abdominal Neoplasms
1
2004
1
0.230
Why?
Pelvic Neoplasms
1
2004
8
0.230
Why?
Adenoviridae
2
2024
67
0.230
Why?
Carcinoid Tumor
1
2004
3
0.220
Why?
Hepatocyte Nuclear Factor 3-alpha
2
2015
2
0.220
Why?
Smartphone
1
2024
63
0.220
Why?
Mobile Applications
1
2024
61
0.220
Why?
Specimen Handling
3
2013
31
0.210
Why?
Ureteral Neoplasms
2
2020
6
0.210
Why?
Surgical Staplers
1
2003
2
0.210
Why?
Hemostasis, Surgical
1
2003
7
0.210
Why?
Randomized Controlled Trials as Topic
3
2024
381
0.200
Why?
Taxoids
2
2016
37
0.200
Why?
African Americans
3
2012
352
0.200
Why?
Sarcoma, Endometrial Stromal
1
2002
3
0.200
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2014
74
0.200
Why?
Clinical Trials as Topic
2
2018
214
0.200
Why?
Mitomycin
1
2002
19
0.190
Why?
Eosinophilia
1
2002
8
0.190
Why?
Urination
2
2012
13
0.190
Why?
Decision Making
2
2018
175
0.190
Why?
Lymphoma, Follicular
1
2002
13
0.190
Why?
Antibiotics, Antineoplastic
1
2002
32
0.190
Why?
Lidocaine
1
2001
27
0.190
Why?
Lymphoma, B-Cell
1
2002
18
0.190
Why?
Patient Discharge
2
2014
104
0.190
Why?
Anesthetics, Local
1
2001
12
0.190
Why?
Pelvis
3
2011
38
0.190
Why?
Genital Neoplasms, Female
1
2002
67
0.190
Why?
Aminolevulinic Acid
2
2014
14
0.190
Why?
Urinary Bladder
5
2014
119
0.180
Why?
Infertility, Male
2
2006
23
0.180
Why?
Models, Organizational
1
2021
18
0.180
Why?
Delivery of Health Care, Integrated
1
2021
14
0.180
Why?
Recurrence
3
2012
321
0.180
Why?
Malnutrition
2
2011
31
0.170
Why?
Muscle, Smooth
3
2014
40
0.170
Why?
Cysts
2
2007
22
0.170
Why?
Leuprolide
1
2020
5
0.170
Why?
Endometrial Neoplasms
1
2002
189
0.170
Why?
Pyrimidinones
1
2020
16
0.170
Why?
Phenylurea Compounds
1
2020
16
0.170
Why?
Chromosomes, Human, Pair 8
1
2020
14
0.170
Why?
Genetic Vectors
1
2020
114
0.170
Why?
Seminal Vesicles
1
2020
5
0.170
Why?
Lysosomes
1
2020
56
0.170
Why?
Gene Expression Regulation, Neoplastic
2
2014
461
0.170
Why?
Parkinson Disease
1
2020
46
0.160
Why?
Genetic Therapy
1
2020
123
0.160
Why?
Ureteral Diseases
1
1999
1
0.160
Why?
Kidney Pelvis
1
1999
5
0.160
Why?
Adolescent
9
2014
3104
0.160
Why?
Neoplasm Metastasis
1
2020
160
0.160
Why?
Lymphocytes
1
2019
90
0.160
Why?
Abiraterone Acetate
1
2018
3
0.150
Why?
Orchiectomy
2
2020
12
0.150
Why?
Minimally Invasive Surgical Procedures
2
2017
70
0.150
Why?
Population Dynamics
1
2018
30
0.150
Why?
Induction Chemotherapy
1
2018
6
0.150
Why?
Neutrophils
1
2019
181
0.150
Why?
Urinalysis
1
2018
11
0.150
Why?
Cisplatin
4
2022
179
0.150
Why?
Intestines
2
2012
118
0.150
Why?
Perioperative Period
1
2018
7
0.150
Why?
Reproducibility of Results
6
2014
769
0.150
Why?
Tomography, X-Ray Computed
3
2018
473
0.150
Why?
Sensitivity and Specificity
5
2009
520
0.150
Why?
Tobacco Smoking
1
2018
38
0.150
Why?
Androstane-3,17-diol
1
2017
9
0.140
Why?
Databases, Factual
5
2017
253
0.140
Why?
Anabolic Agents
1
2017
12
0.140
Why?
Urologists
1
2017
5
0.140
Why?
Aldo-Keto Reductase Family 1 Member C3
1
2017
21
0.140
Why?
Receptors, GABA-A
1
2017
18
0.140
Why?
Physicians, Primary Care
1
2017
9
0.140
Why?
Insurance Coverage
1
2017
31
0.140
Why?
Patient Reported Outcome Measures
1
2018
64
0.140
Why?
Pain, Postoperative
3
2007
62
0.140
Why?
Postoperative Care
3
2007
68
0.140
Why?
Comorbidity
4
2014
257
0.140
Why?
Urethral Neoplasms
2
2009
3
0.140
Why?
Remission Induction
1
2017
53
0.140
Why?
Glutathione Transferase
1
1997
32
0.140
Why?
Hematocrit
2
2010
26
0.140
Why?
Hydronephrosis
3
2020
11
0.140
Why?
Carcinoma, Squamous Cell
2
2012
163
0.140
Why?
Mitochondria
1
2020
369
0.130
Why?
Androstenols
1
2016
2
0.130
Why?
Phenylthiohydantoin
1
2016
3
0.130
Why?
Nitriles
1
2016
33
0.130
Why?
Drug Administration Schedule
3
2013
223
0.130
Why?
Microtubule-Associated Proteins
1
2017
49
0.130
Why?
Reoperation
1
2017
145
0.130
Why?
Benzamides
1
2016
34
0.130
Why?
Receptors, Androgen
2
2006
26
0.130
Why?
Logistic Models
5
2012
407
0.130
Why?
Quality of Health Care
2
2013
80
0.120
Why?
Radiopharmaceuticals
1
2016
71
0.120
Why?
Anastomosis, Surgical
4
2012
37
0.120
Why?
Research Design
3
2018
183
0.120
Why?
Organ Size
3
2011
86
0.120
Why?
Rectum
3
2001
50
0.120
Why?
Translations
1
2014
2
0.120
Why?
Urinary Tract
1
2014
3
0.120
Why?
Immunohistochemistry
5
2015
461
0.120
Why?
Cell Cycle Proteins
1
2017
187
0.120
Why?
Nuclear Proteins
1
2017
247
0.120
Why?
Semen
1
1995
29
0.110
Why?
Diagnosis, Differential
3
2007
369
0.110
Why?
RNA, Messenger
1
2017
657
0.110
Why?
Forecasting
1
2014
76
0.110
Why?
Photosensitizing Agents
1
2014
35
0.110
Why?
Octamer Transcription Factor-3
1
2014
2
0.110
Why?
Tennessee
6
2014
26
0.110
Why?
Antibodies
1
1995
124
0.110
Why?
Income
1
2014
38
0.110
Why?
Young Adult
4
2018
2714
0.110
Why?
Postoperative Period
2
2012
67
0.110
Why?
Child Health Services
1
2013
7
0.110
Why?
Carcinoma, Small Cell
1
2013
14
0.110
Why?
Cell Proliferation
2
2017
802
0.100
Why?
International Classification of Diseases
1
2013
36
0.100
Why?
Pathology
1
2013
8
0.100
Why?
Biopsy, Large-Core Needle
1
2013
7
0.100
Why?
Prevalence
3
2019
496
0.100
Why?
Interdisciplinary Communication
1
2013
19
0.100
Why?
Penis
1
1993
16
0.100
Why?
Pelvic Pain
1
2013
10
0.100
Why?
Hematuria
1
2013
10
0.100
Why?
Microsurgery
1
1993
45
0.100
Why?
Psychometrics
3
2014
121
0.100
Why?
Smoking Cessation
1
2018
408
0.100
Why?
Neoplastic Cells, Circulating
3
2005
25
0.100
Why?
Health Services Accessibility
1
2014
94
0.100
Why?
Population Surveillance
1
2013
86
0.100
Why?
Osteomyelitis
1
2013
14
0.100
Why?
Hospitals, High-Volume
1
2012
8
0.100
Why?
ABO Blood-Group System
1
2012
7
0.100
Why?
Organ Sparing Treatments
1
2012
2
0.100
Why?
Pilot Projects
3
2024
430
0.100
Why?
Glucocorticoids
1
2013
115
0.100
Why?
Epidemiologic Methods
2
2009
21
0.100
Why?
Urinary Tract Infections
1
2013
39
0.100
Why?
Healthcare Disparities
1
2013
90
0.100
Why?
Palliative Care
2
2011
82
0.100
Why?
Antigens, Differentiation
1
2012
21
0.100
Why?
Ovarian Neoplasms
1
2018
588
0.100
Why?
Chemoradiotherapy
1
2012
44
0.100
Why?
Emergency Service, Hospital
1
2013
120
0.100
Why?
Antibodies, Heterophile
1
2011
3
0.100
Why?
Incidental Findings
1
2011
13
0.090
Why?
Case-Control Studies
4
2020
719
0.090
Why?
Lymphocele
1
2011
2
0.090
Why?
Kidney Tubules, Collecting
1
2011
4
0.090
Why?
Lymphedema
1
2011
15
0.090
Why?
Dissection
1
2011
20
0.090
Why?
F2-Isoprostanes
1
2011
2
0.090
Why?
Muscle, Skeletal
1
2016
633
0.090
Why?
Muscles
2
2022
72
0.090
Why?
Ileus
1
2011
7
0.090
Why?
Vascular System Injuries
1
2011
19
0.090
Why?
Intubation, Gastrointestinal
1
2011
11
0.090
Why?
Probability
2
2009
78
0.090
Why?
Obesity
2
2007
667
0.090
Why?
Single-Blind Method
2
2018
44
0.090
Why?
Elective Surgical Procedures
1
2011
70
0.090
Why?
Wounds and Injuries
1
2013
181
0.090
Why?
Models, Statistical
1
2011
127
0.090
Why?
Venous Thrombosis
1
2011
98
0.090
Why?
History, 20th Century
2
2021
84
0.090
Why?
Flutamide
3
2006
6
0.090
Why?
Monitoring, Physiologic
2
2018
57
0.080
Why?
Pulmonary Embolism
1
2011
126
0.080
Why?
Congresses as Topic
1
2010
35
0.080
Why?
Telemedicine
2
2024
174
0.080
Why?
Prostatic Diseases
1
2009
3
0.080
Why?
Pain Measurement
2
2007
166
0.080
Why?
Health Facility Size
1
2009
3
0.080
Why?
Feasibility Studies
3
2006
193
0.080
Why?
Surgery Department, Hospital
1
2009
13
0.080
Why?
Hospital Mortality
4
2012
147
0.080
Why?
Sutures
2
2013
15
0.080
Why?
Administration, Oral
2
2020
188
0.080
Why?
Early Diagnosis
2
2007
32
0.080
Why?
Chromosomes, Human, Pair 3
1
2008
17
0.080
Why?
Hypoxia-Inducible Factor 1
1
2008
11
0.080
Why?
Genes, Tumor Suppressor
1
2008
39
0.080
Why?
Endoscopy
1
2009
56
0.080
Why?
Observation
1
2008
5
0.080
Why?
Chi-Square Distribution
4
2012
145
0.080
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2009
77
0.080
Why?
Radiotherapy, Conformal
1
2008
15
0.070
Why?
Odds Ratio
2
2014
236
0.070
Why?
Vinblastine
2
2020
6
0.070
Why?
Protein-Tyrosine Kinases
1
2008
97
0.070
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2008
54
0.070
Why?
Methotrexate
2
2020
35
0.070
Why?
Aspirin
1
2009
124
0.070
Why?
C-Peptide
1
2007
8
0.070
Why?
Urinary Bladder Neck Obstruction
1
2007
4
0.070
Why?
Urination Disorders
1
2007
9
0.070
Why?
Risk
3
2014
136
0.070
Why?
Urethral Stricture
1
2007
7
0.070
Why?
Doxorubicin
2
2020
77
0.070
Why?
Deoxycytidine
2
2020
65
0.070
Why?
Azasteroids
1
2007
1
0.070
Why?
Glycated Hemoglobin A
1
2007
64
0.070
Why?
Carbon Radioisotopes
1
2007
20
0.070
Why?
Quality Indicators, Health Care
1
2007
49
0.070
Why?
Leptin
1
2007
67
0.070
Why?
Preoperative Period
2
2021
15
0.070
Why?
Goserelin
2
1997
2
0.070
Why?
Academic Medical Centers
1
2007
75
0.070
Why?
Proctitis
1
2006
1
0.070
Why?
Treatment Failure
1
2007
68
0.070
Why?
Retroperitoneal Space
2
2007
9
0.070
Why?
Sperm Banks
1
2006
1
0.070
Why?
Intensive Care Units
2
2009
49
0.070
Why?
Body Size
1
2006
37
0.070
Why?
Palpation
2
1997
7
0.070
Why?
Diarrhea
1
2006
55
0.070
Why?
Haplotypes
2
2020
283
0.070
Why?
Body Height
1
2006
57
0.070
Why?
Oncogene Proteins
1
2006
22
0.070
Why?
Oxidative Stress
1
2011
667
0.070
Why?
Femoral Nerve
1
2006
2
0.060
Why?
Androgens
1
2006
47
0.060
Why?
Sex Factors
3
2020
465
0.060
Why?
Enzyme Inhibitors
1
2007
249
0.060
Why?
Laparoscopes
1
2005
3
0.060
Why?
Magnetic Resonance Imaging
2
2018
817
0.060
Why?
Renal Veins
1
2005
7
0.060
Why?
Thrombectomy
1
2005
28
0.060
Why?
Double-Blind Method
2
2007
414
0.060
Why?
Regression Analysis
2
2017
210
0.060
Why?
Surgical Stomas
1
2004
6
0.060
Why?
Ureter
1
2004
8
0.060
Why?
Epithelial Cells
1
2006
247
0.060
Why?
Ileum
1
2004
25
0.060
Why?
Penile Neoplasms
1
2004
12
0.060
Why?
Intestinal Diseases
1
2004
11
0.060
Why?
Intraoperative Period
1
2004
21
0.060
Why?
Sickness Impact Profile
1
2003
4
0.050
Why?
Ultrasonography
3
2000
240
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2006
281
0.050
Why?
Registries
2
2017
387
0.050
Why?
Health Surveys
1
2003
82
0.050
Why?
Signal Transduction
3
2017
1433
0.050
Why?
Anesthesia
1
2003
26
0.050
Why?
Pelvic Exenteration
1
2002
2
0.050
Why?
Genitalia, Female
1
2002
6
0.050
Why?
Preoperative Care
3
1997
81
0.050
Why?
Tumor Cells, Cultured
2
2017
315
0.050
Why?
Vagina
1
2002
42
0.050
Why?
Tumor Microenvironment
1
2024
176
0.050
Why?
Carboplatin
1
2022
111
0.050
Why?
Administration, Rectal
1
2001
5
0.050
Why?
Hysterectomy
1
2002
85
0.050
Why?
Health Knowledge, Attitudes, Practice
1
2024
293
0.050
Why?
Cost Control
1
2021
9
0.050
Why?
Value-Based Purchasing
1
2021
3
0.050
Why?
Constriction, Pathologic
2
2012
34
0.050
Why?
Nephroureterectomy
1
2020
1
0.040
Why?
History, 21st Century
1
2021
49
0.040
Why?
Comparative Effectiveness Research
1
2020
12
0.040
Why?
Health Status
1
2001
148
0.040
Why?
Paraparesis, Spastic
1
2000
1
0.040
Why?
Nomograms
1
2020
9
0.040
Why?
Multifactorial Inheritance
1
2020
12
0.040
Why?
Propensity Score
1
2020
54
0.040
Why?
Community Networks
1
2020
10
0.040
Why?
Injections, Subcutaneous
1
2020
60
0.040
Why?
Dopaminergic Neurons
1
2020
16
0.040
Why?
Protective Factors
1
2020
16
0.040
Why?
Heterozygote
1
2020
65
0.040
Why?
Adenosine Triphosphatases
1
2000
49
0.040
Why?
Linkage Disequilibrium
1
2020
108
0.040
Why?
Urologic Surgical Procedures, Male
2
2014
15
0.040
Why?
Genetic Loci
1
2020
75
0.040
Why?
Ureteroscopy
1
1999
5
0.040
Why?
Urography
1
1999
12
0.040
Why?
Mutation
2
2020
843
0.040
Why?
Genome-Wide Association Study
1
2020
234
0.040
Why?
Transcription, Genetic
2
2014
403
0.040
Why?
Prophylactic Surgical Procedures
1
2018
7
0.040
Why?
Narrow Band Imaging
1
2018
1
0.040
Why?
Ovariectomy
1
2018
53
0.040
Why?
Watchful Waiting
1
2018
18
0.040
Why?
Random Allocation
1
2018
151
0.040
Why?
Chronic Disease
1
1999
271
0.040
Why?
Gene Expression Profiling
1
2020
452
0.040
Why?
Delayed Diagnosis
1
2017
19
0.040
Why?
ErbB Receptors
1
2017
100
0.030
Why?
American Cancer Society
1
2017
4
0.030
Why?
Aurora Kinase A
1
2017
3
0.030
Why?
Child, Preschool
3
2013
1133
0.030
Why?
Antigens, Surface
1
1997
39
0.030
Why?
Counseling
2
2007
55
0.030
Why?
Epithelium
1
1997
39
0.030
Why?
Brachytherapy
2
2007
51
0.030
Why?
Medicaid
1
2017
54
0.030
Why?
Antigens, Neoplasm
1
1997
56
0.030
Why?
Cardiovascular Diseases
1
2020
364
0.030
Why?
Selection Bias
2
2010
13
0.030
Why?
Keratin-14
1
2015
1
0.030
Why?
DNA Methylation
1
2017
151
0.030
Why?
Tissue Array Analysis
1
2015
24
0.030
Why?
Linguistics
1
2014
4
0.030
Why?
Republic of Korea
1
2014
11
0.030
Why?
Sperm Motility
1
1995
16
0.030
Why?
Multimodal Imaging
1
2014
22
0.030
Why?
North America
1
2014
39
0.030
Why?
Molecular Targeted Therapy
1
2016
135
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2015
194
0.030
Why?
Europe
1
2014
98
0.030
Why?
Embryonic Stem Cells
1
2014
8
0.030
Why?
Oklahoma
1
2017
993
0.030
Why?
Child
3
2013
2225
0.030
Why?
Open Reading Frames
1
2014
37
0.030
Why?
Diethylstilbestrol
1
1994
2
0.030
Why?
Urodynamics
1
1994
5
0.030
Why?
Sex Characteristics
1
2015
172
0.030
Why?
Mice
2
2015
4621
0.030
Why?
Maryland
1
2013
7
0.030
Why?
New York
1
2013
17
0.030
Why?
Adrenalectomy
1
1994
13
0.030
Why?
Databases, Genetic
1
2014
48
0.030
Why?
Florida
1
2013
54
0.030
Why?
Quantitative Trait Loci
1
2014
55
0.030
Why?
Mutation, Missense
1
2014
69
0.030
Why?
Ligation
1
2013
39
0.030
Why?
Neural Tube Defects
1
1994
20
0.030
Why?
Estrogens
1
1994
56
0.030
Why?
DNA Mutational Analysis
2
2006
94
0.030
Why?
Databases, Bibliographic
1
2013
10
0.030
Why?
Transcriptome
1
2015
214
0.030
Why?
Cell Nucleus
1
2014
136
0.030
Why?
Veins
1
1993
19
0.030
Why?
Penile Erection
1
1993
3
0.030
Why?
Constriction
1
1993
14
0.030
Why?
Alleles
1
2014
350
0.030
Why?
Vacuum
1
1993
11
0.030
Why?
Infant
2
2013
987
0.030
Why?
Cell Transformation, Neoplastic
1
2014
119
0.030
Why?
Equipment and Supplies
1
1993
12
0.030
Why?
Quality Assurance, Health Care
1
2013
62
0.030
Why?
Peripheral Vascular Diseases
1
1993
64
0.030
Why?
Genotype
1
2014
456
0.030
Why?
Patient Care Team
1
2013
67
0.030
Why?
Arteries
1
1993
65
0.030
Why?
Genetic Variation
1
2014
241
0.020
Why?
Cell Differentiation
1
2015
406
0.020
Why?
SEER Program
1
2012
47
0.020
Why?
Sequence Analysis, DNA
1
2014
369
0.020
Why?
Cadherins
1
2012
24
0.020
Why?
Mice, SCID
1
2012
60
0.020
Why?
Patient Satisfaction
1
1993
96
0.020
Why?
Neoplasm Transplantation
1
2012
89
0.020
Why?
Mice, Knockout
1
2015
836
0.020
Why?
Medicare
1
2012
124
0.020
Why?
False Positive Reactions
1
2011
31
0.020
Why?
Spinal Cord
1
1994
208
0.020
Why?
Drug Implants
1
2011
14
0.020
Why?
Mass Screening
1
2013
152
0.020
Why?
Pneumonia, Aspiration
1
2011
4
0.020
Why?
Recovery of Function
1
2012
116
0.020
Why?
Gastrointestinal Motility
1
2011
30
0.020
Why?
Digital Rectal Examination
1
2010
3
0.020
Why?
Microtomy
1
2010
2
0.020
Why?
Serum Albumin
1
2011
35
0.020
Why?
Weight Loss
1
2011
80
0.020
Why?
Statistics, Nonparametric
1
2010
82
0.020
Why?
Animals
2
2015
10370
0.020
Why?
Disease Models, Animal
1
2015
1454
0.020
Why?
Databases as Topic
1
2009
22
0.020
Why?
Guideline Adherence
1
2010
94
0.020
Why?
Cross-Sectional Studies
1
2012
957
0.020
Why?
Demography
1
2009
93
0.020
Why?
Reference Values
1
2009
199
0.020
Why?
False Negative Reactions
2
1998
24
0.020
Why?
Rats
1
2012
1570
0.020
Why?
Radiography
1
2009
202
0.020
Why?
Urinary Catheterization
1
2007
15
0.020
Why?
Adiponectin
1
2007
29
0.020
Why?
Angiomyolipoma
1
2007
2
0.020
Why?
Awards and Prizes
1
2007
9
0.020
Why?
Adenoma, Oxyphilic
1
2007
5
0.020
Why?
Radioisotope Teletherapy
1
2007
1
0.020
Why?
Dutasteride
1
2007
1
0.020
Why?
Carcinoma, Papillary
1
2007
18
0.020
Why?
Biomarkers
1
2011
756
0.020
Why?
Accreditation
1
2007
35
0.020
Why?
Diabetes Complications
1
2007
66
0.020
Why?
Radiation-Sensitizing Agents
1
2007
32
0.020
Why?
Waist-Hip Ratio
1
2006
8
0.020
Why?
Southeastern United States
1
2006
4
0.020
Why?
Metabolic Syndrome
1
2007
78
0.020
Why?
Abdomen
1
2006
41
0.020
Why?
Global Health
1
2007
51
0.020
Why?
Protein Deglycase DJ-1
1
2006
2
0.020
Why?
Drug Stability
1
2006
23
0.020
Why?
Electrophoresis, Gel, Two-Dimensional
1
2006
39
0.020
Why?
Microscopy, Electron
1
2006
94
0.020
Why?
Radiotherapy Dosage
1
2006
104
0.020
Why?
Physician-Patient Relations
1
2007
115
0.020
Why?
Attitude to Health
1
2006
89
0.020
Why?
Ketorolac
1
2005
9
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
327
0.020
Why?
Clinical Competence
1
2007
224
0.020
Why?
Transfection
1
2006
317
0.020
Why?
Infusions, Intravenous
1
2005
102
0.020
Why?
Cause of Death
1
2005
72
0.010
Why?
Curriculum
1
2007
289
0.010
Why?
Early Ambulation
1
2004
3
0.010
Why?
Gene Expression
1
2006
415
0.010
Why?
Bandages
1
2004
14
0.010
Why?
Hospital Costs
1
2003
29
0.010
Why?
Intestinal Pseudo-Obstruction
1
2002
4
0.010
Why?
Cell Line, Tumor
1
2006
1314
0.010
Why?
Spastin
1
2000
1
0.010
Why?
Chromosomes, Human, Pair 2
1
2000
7
0.010
Why?
England
1
2000
38
0.010
Why?
Pedigree
1
2000
155
0.010
Why?
Genetic Linkage
1
2000
95
0.010
Why?
Phenotype
1
2000
680
0.010
Why?
Smoking
1
2002
473
0.010
Why?
Glutamate Carboxypeptidase II
1
1997
2
0.010
Why?
Drug Therapy, Combination
1
1997
207
0.010
Why?
Polymerase Chain Reaction
1
1997
268
0.010
Why?
Brain
1
2000
739
0.010
Why?
Compliance
1
1994
21
0.010
Why?
Pressure
1
1994
90
0.010
Why?
Infant, Newborn
1
1994
867
0.010
Why?
Cookson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (581)
Explore
_
Co-Authors (20)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_